New insights into beneficial pathways that also operate in tumors and can regulate anti-tumor responses

Main Category: Lung Cancer
Also Included In: Immune System / Vaccines;  Genetics
Article Date: 24 Jul 2013 - 1:00 PDT Current ratings for:
New insights into beneficial pathways that also operate in tumors and can regulate anti-tumor responses

Researchers at Moffitt Cancer Center and Tianjin Medical University Cancer Institute and Hospital in China have discovered a gene expression signature that may lead to new immune therapies for lung cancer patients. They found that NF-?B, a protein complex known to promote tumor growth, may also have the ability to boost the immune system to eliminate cancerous cells before they harm, as well as promote antitumor responses.

The study appeared in a recent issue of The Journal of Clinical Investigation.

NF-?B is a protein complex that controls gene expression. The regulation of NF-?B also plays an important role in regulating the body's immune response to infection. Incorrect regulation of NF-kB has been linked to cancer, inflammatory and autoimmune diseases, septic shock, viral infection, and improper immune development.

"New insight into how tumor pathways regulate the anti-tumor immune response may help us to devise new ways for improving immune therapy," said study lead author Amer Beg, Ph.D., senior member of Moffitt's Immunology Program. "Studies are now underway to start a clinical trial to determine whether the novel gene expression signature described in this work may help initiate new and better immunotherapy treatments."

According to Beg, NF-?B proteins regulate key genes involved in immune response, inflammation, cell death and cell growth. Work in his lab is aimed at a better understanding of how NF-?B regulates immune response and how the consequences of impaired regulation of responses are related to disease.

The researchers analyzed the role of NF-?B in lung cancer cells that were used to develop the NF-?B gene signature. Key studies in mice showed that NF-?B can mediate immune rejection of tumors. The studies were then extended to human tumor specimens. "In this study we found that NF-?B activity is strongly associated with immune system T-cell infiltration in lung cancer," explained study co-author Dung-Tsa Chen, Ph.D., member of the Biostatistics Department at Moffitt. "Multiple genes, capable of enhancing T-cell responses, were found in the NF-?B signature. This means that NF-?B, thought of as a tumor promoter, also helps facilitate an immune response."

Their finding - that the presence of high levels of NF-?B in lung cancer tumors can act as a suppressor" provides new insight into how tumor pathways regulate the anti-tumor response.

"T-cell presence in tumors can be associated with immune surveillance and improved patient survival," explained Beg. "The focus of immune therapy, boosting T cell-induced responses against solid tumors, has shown considerable promise. However, tolerance-inducing mechanisms and the presence of suppressive cell types in the tumor microenvironment can dampen the response to immunotherapy. Our findings provide new insights into beneficial pathways that also operate in tumors and can regulate anti-tumor responses."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our lung cancer section for the latest news on this subject.

This work was supported by a National Cancer Institute lung cancer SPORE grant (P50 CA119997), the National Functional Genomics Center, and the James and Esther King Biomedical Research Program.

H. Lee Moffitt Cancer Center & Research Institute

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

H. Lee Moffitt Cancer Center & Research Institute. "New insights into beneficial pathways that also operate in tumors and can regulate anti-tumor responses." Medical News Today. MediLexicon, Intl., 24 Jul. 2013. Web.
24 Jul. 2013. APA
H. Lee Moffitt Cancer Center & Research Institute. (2013, July 24). "New insights into beneficial pathways that also operate in tumors and can regulate anti-tumor responses." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/263799.php.

Please note: If no author information is provided, the source is cited instead.

'New insights into beneficial pathways that also operate in tumors and can regulate anti-tumor responses'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here